Results 11 to 20 of about 38,804 (257)
BMJ Open, 2021 Objectives Hyperhomocysteinemia is an independent risk factor for cardiovascular diseases. We aimed to investigate the prevalence and risk factors for hyperhomocysteinemia, especially modifiable lifestyle factors, such as smoking behaviour and dietary ...
Yanhui Dong +12 more
doaj +2 more sources
Journal of Dental Sciences, 2021 Background/purpose: Our previous study found that 70 of 884 burning mouth syndrome (BMS) patients have serum gastric parietal cell antibody (GPCA) positivity but without thyroglobulin antibody (TGA) and thyroid microsomal antibody (TMA) (so-called GPCA ...
Ying-Tai Jin +5 more
doaj +2 more sources
Journal of Dental Sciences, 2020 Background/purpose: Our previous study found that 170 of 884 burning mouth syndrome (BMS) patients have hyperhomocysteinemia. This study assessed whether these 170 BMS patients with hyperhomocysteinemia had significantly higher frequencies of anemia ...
Meng-Ling Chiang +2 more
doaj +2 more sources
Hyperhomocysteinemia: Clinical Insights [PDF]
Journal of Central Nervous System Disease, 2020 Homocysteine (Hcy) is a sulfhydryl-containing amino acid, and intermediate metabolite formed in metabolising methionine (Met) to cysteine (Cys); defective Met metabolism can increase Hcy. The effect of hyperhomocysteinemia (HHcy) on human health, is well described and associated with multiple clinical conditions. HHcy is considered to be an independent
F. Al Mutairi
openaire +4 more sources
Anemia, hematinic deficiencies, and gastric parietal cell antibody positivity in oral lichen planus patients with or without hyperhomocysteinemia [PDF]
Journal of Dental SciencesBackground/purpose: Our previous study found that 124 of 588 oral lichen planus (OLP) patients have hyperhomocysteinemia. This study assessed whether these 124 OLP patients with hyperhomocysteinemia (hyperhomocysteinemia/OLP patients) had significantly ...
Yi-Pang Lee +5 more
doaj +2 more sources
Inhibiting MARSs reduces hyperhomocysteinemia‐associated neural tube and congenital heart defects
EMBO Molecular Medicine, 2020 Hyperhomocysteinemia is a common metabolic disorder that imposes major adverse health consequences. Reducing homocysteine levels, however, is not always effective against hyperhomocysteinemia‐associated pathologies.
Xinyu Mei +21 more
doaj +2 more sources
Hyperhomocysteinemia leads to exacerbation of ischemic brain damage: Role of GluN2A NMDA receptors
Neurobiology of Disease, 2019 Hyperhomocysteinemia has been implicated in several neurodegenerative disorders including ischemic stroke. However, the pathological consequences of ischemic insult in individuals predisposed to hyperhomocysteinemia and the associated etiology are ...
Ankur Jindal +8 more
doaj +2 more sources
Anemia, hematinic deficiencies, hyperhomocysteinemia, and gastric parietal cell antibody positivity in oral lichen planus patients with normocytosis [PDF]
Journal of Dental SciencesBackground/purpose: Normocytosis is defined as having the mean corpuscular volume (MCV) between 80 fL and 99.9 fL. This study evaluated whether the 474 oral lichen planus (OLP) patients with normocytosis (so-called normocytosis/OLP patients) had ...
Julia Yu-Fong Chang +5 more
doaj +2 more sources
Redox Biology, 2018 Hyperhomocysteinemia due to cystathionine beta synthase (CBS) deficiency is associated with diverse cognitive dysfunction. Considering the role of the serine/threonine kinase DYRK1A, not only in developmental defects with life-long structural and ...
Vanessa Baloula +5 more
doaj +2 more sources
Journal of the Formosan Medical Association, 2018 Background/Purpose: Atrophic glossitis (AG) patients are prone to have anemia, hematinic deficiencies, hyperhomocysteinemia, and serum gastric parietal cell antibody (GPCA) positivity.
Chun-Pin Chiang +5 more
doaj +2 more sources